Compare Suncor Energy Inc. (SU) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suncor Energy Inc. vs Tilray Brands Inc — how do they compare? Suncor Energy Inc. trades at $70.57 (market cap $80.03B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Suncor Energy Inc. is far larger — about 145.8× Tilray Brands Inc's market cap, and Suncor Energy Inc. pays a 2.49% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Suncor Energy Inc. for 57 Days and Tilray Brands Inc for 31 Days on average.
| SU | TLRY | |
|---|---|---|
Market Cap | $80.03B | $549.01M |
Volume | 2,907,827 | 3,292,073 |
Sector | Energy | Health |
52-Week High | $71.87 | $21.00 |
52-Week Low | $38.17 | $3.57 |
Typical Hold Time | 57 Days | 31 Days |
Enterprise Value | $86.58B | $716.15M |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Suncor Energy (SU) trades at $70.91, up 3.94% today, reflecting strong momentum near recent highs. The stock exhibits a bullish technical trend with support at $68 and resistance at $69. Fundamentally, SU maintains solid profitability with a 14.7% net income margin and attractive valuation at a P/E of 12.98. Recent Q2 2026 earnings beat expectations, and the company announced a $0.60 dividend for H2-2026. Cash flow remains robust, supporting shareholder returns via buybacks.
The outlook for SU is positive, driven by strong cash generation, debt reduction, and strategic asset sales. Investment appeal lies in its integrated model, shareholder returns, and exposure to global energy markets. Key risks include commodity price volatility, operational disruptions from weather, and execution of leadership transition. Analyst consensus is strongly bullish with 74% buy ratings, signaling confidence in continued performance.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
